Kuan-Pin Su  蘇冠賓 

Academic Appointments

  • Deputy Superintendent, An-Nan Hospital, China Medical University, Tainan (2020.3-)
          中國醫藥大學安南醫院 副院長(2020.3-)
  • Professor of Psychiatry and Neurosciences (2012.11-), College of Medicine, China Medical University (CMU)
          中國醫藥大學醫學院精神醫學及神經科學 教授(2012.11-)
  • Director, Mind-Body Interface Research Centre, China Medical University Hospital (2006/08-)
          身心介面(Mind-Body Interface)研究中心 主持人(2006.8-)
  • Chief, Department of General Psychiatry, China Medical University Hospital (2003/12-)
          中國醫藥大學附設醫院 精神醫學部一般精神科 主任(2004.3-)
  • Honorary Professor of Institute of Psychiatry-King's College London (2008/11-)
          倫敦大學國王學院 訪問教授(2008.11-)

Education

  • PhD, Institute of Psychiatry, King’s College London, UK
          倫敦大學國王學院 精神醫學所 博士 (2005-2008)
  • Chief Resident and Resident, Taipei City Psychiatric Centre (1995-1999)
          台北市精神病院總住院醫師兼住院醫師 (1995-1999)
  • M.D., Kaohsiung Medical College, Kaohsiung, Taiwan (1988-1995)
          高雄醫學大學 醫學士(1988-1995)

Professional Experiences

  • Vice Dean, College of Medicine, China Medical University (CMU) (2017.8-2019.4)
 

          中國醫藥大學醫學院 副院長 (2017.8-2019.4)

  • Chairman, Graduate Institute of Neural and Cognitive Sciences, China Medical University (CMU) (2014.8-2017.8)
          神經科學及認知科學研究所所長 (2014.8-2017.8)
  • Attending physician, Department of Psychiatry, Wan Fang Medical Centre & Taipei Medical University Hospital (1995.7-2002.3)
          台北市立療養院住院醫師、總醫師、兼任主治醫師 (1995.7-2002.3)

Research Interests

  • Translational medicine, connecting the bench and beside with novel interdisciplinary approaches to promote medical research.
  • Genomic studies in psychiatric disorders and pharmacogenetics.
  • Neurocognitive functioning in psychiatric disorders.
  • New treatments for depressive disorders, including omega-3 fatty acids, transcranial magnetic stimulations, Chinese medicine...
  • Brain imaging studies (fMRI & PET) in psychiatric disorders and neural circuitry mechanisms of both non-pharmacotherapy and antidepressant drugs.
  • Cellular and molecular mechanisms of psychiatric disorders and pharmacotherapy.

Awards

  • 2020, 全球前2%頂尖科學家
  • 2020, UM Macao Distinguished Visiting Scholar
  • 2019, Outstanding Research Award (ORA) of the Ministry of Science and Technology (MoST), Taiwan
  • 2018, China Medical University Distinguishing Professor of the Year
  • 2016, The International Society for the Study of Fatty Acids and Lipids (ISSFAL): Early Career Award
  • 2013, Psychopharmacology Award from the British Association for Psychopharmacology (UK)
  • 2013, GlaxoSmithKline Depression and Anxiety Research Award, Taiwanese Society of Psychiatry, Taiwan
  • 2013, Professor Wen-Ho Chang Research Award, Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology, Taiwan
  • 2012, Pacific Rim College of Psychiatrists: Young Psychiatrists Award
  • 2012 and 2014, The International Society for the Study of Fatty Acids and Lipids (ISSFAL): New Investigator Award
  • 2012, Teaching Excellency Award, China Medical University Hospital
  • 2012, Psychiatric Research Society Annual Meeting Travel Award (USA)
  • 2011, Thomson Reuters Research Front Award
  • 2011, GlaxoSmithKline Depression and Anxiety Research Award, Taiwanese Society of Psychiatry, Taiwan
  • 2011, Initiative Research Cooperation among Top Universities between UK and Taiwan, National Science Council, Taiwan
  • 2011, Scientific Physician, China Medical University Hospital (CMUH)
  • 2010, Ta-You Wu Memorial Award, National Science Council, Taiwan
  • 2010, the Elite Physician of the Year, CMUH
  • 2009 and 2004, the Best Physician of the Year, CMUH
  • 2008, Professor Wen-Ho Chang Research Award, Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology, Taiwan
  • 2008, Professor Robert Kerwin International Award from the British Association for Psychopharmacology (UK)
  • 2008-2010, National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (USA)
  • 2007-2008, China Medical University Elite Faculty Scholarships
  • 2006-2007, China Medical University Hospital Elite Scholarships
  • 2006, Professor Janssen’s Schizophrenia Research Award, Society of Psychiatry, Taiwan
  • 2005-2006, Elite Program of Taiwan Merit Scholarships (TMS), Ministry of Education, Taiwan
Committee, Membership & Certification
  • Associate Editor of Brain, Behavior, and Immunity (BBI) (2019-)
           2019年, 期刊Brain, Behavior, and Immunity (BBI) 副主編 (2019-)
  • Associate Editor of Brain, Behavior, and Immunity-Health (BBI-H) (2019-)
           2019年, Brain, Behavior, and Immunity-Health (BBI-H) 副主編 (2019-)
  • President of Taiwanese Society for Nutritional Psychiatry Research (TSNPR) (2016-19)
          2016年, 台灣營養精神醫學研究學會Taiwan Society for Nutritional Psychiatry Research (TSNPR) 理事長(2016- 2019)
  • Member of Board of Directors, the International Society for the Study of Fatty Acids and Lipids (ISSFAL) (2016-2020)
         2016年, 國際脂肪酸研究學會 理事(2016-2020)
  • Editorial board member of Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) (2016-)
         2016年, 期刊Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 編輯委員
  • Council Board Member of the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN) (2015--2018)
          2015-2018年, 台灣生物精神醫學暨神經精神藥理學學會 第七屆理事

Publications  (https://mbilab.lib.cmuh.org.tw/dir/1186)

  1. Kim SW, Su KP*. Using psychoneuroimmunity against COVID-19. Brain Behavior and Immunity 2020 Mar 29. pii: S0889-1591(20)30391-3. doi: 10.1016/j.bbi.2020.03.025.
  2. Sun CF, Chiu WC, Chen PC, Chang HC, Guu TW, Shitya S, Miller AH, Felger C, Chang JPC, Su KP. Depression-free after Interferon-α Exposure Indicates Less Incidence of Depressive disorder: A Longitudinal Study in Taiwan. Brain Behavior and Immunity 2020 May 17, https://doi.org/10.1016/j.bbi.2020.05.044
  3. JPC Chang, V Mondelli, SK Satyanarayanan, YJ Chiang, HT Chen, Su KP*, Pariante CM. Cortisol, Inflammatory Biomarkers and Neurotrophins in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) in Taiwan. Brain Behavior and Immunity 2020 May 8, https://doi.org/10.1016/j.bbi.2020.05.017
  4. Luo XD, Feng JS, Yang Z, Huang OT, Lin JD, Yang B, Su KP, Pan JY. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis. BMC Psychiatry 2020; 20: 248.
  5. Tseng PT, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, Lin PY, Stubbs B, Carvalho AF, Matsuoka YJ, Li DJ, Liang CS, Hsu CW, Chen YW, Shiue YL. The association between melatonin and episodic migraine: a pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy. J Pineal Res. 2020 Apr 29:e12663. doi: 10.1111/jpi.12663. [Epub ahead of print]
  6. Tseng PT, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, Lin PY, Stubbs B, Carvalho AF, Matsuoka YJ, Li DJ, Liang CS, Hsu CW, Chen YW, Shiue YL. The association between melatonin and episodic migraine: a pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy. J Pineal Res. 2020 Apr 29:e12663. doi: 10.1111/jpi.12663. [Epub ahead of print]
  7. Yang CP, Tseng PT, Chang JPC, Su HX, Satyanarayanan SK, Su KP*. Melatonergic agents in the prevention of delirium: A network meta-analysis of randomized controlled trials, Sleep Medicine Reviews 2020 Apr;50:101235. doi.org/10.1016/j.smrv.2019.101235.
  8. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Marx W, Pariante C, Berk M, Jacka F, Su KP*. A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of Affective Disorders 2020 Mar 15;265:233-238. 
  9. Chang JP, Su KP*. Nutrition and immunology in mental health: Precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments. Brain Behavior and Immunity 2020 Mar;85:1-3.
  10. Chang JP, Chang SS, Yang HT, Chen HT, Chien YC, Yang B, Su H, Su KP*. Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases Comorbid Major Depressive Disorder (MDD)- Results from a Randomized Controlled Trial. Brain Behavior and Immunity 2020 Mar;85:14-20.

Contact

E-mail: cobolsu@gmail.com , cobol@cmu.edu.tw